Product Name: Human CLDN18 Antibody (Zolbetuximab, Research Use)
Catalog Number: NBR-0149
Target Name: CLDN18
Trade Name: Zolbetuximab
Antibody Drug Description: Zolbetuximab (development code IMAB362) is an experimental monoclonal antibody against isoform 2 of Claudin-18. It is under investigation for the treatment of gastrointestinal adenocarcinomas and pancreatic tumors. IMAB362 was developed by Ganymed Pharmaceuticals AG. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: CLDN18
Synonyms: Claudin-18; SFTPJ; SFTA5
Target Description: 
Ensembl: ENSG00000066405
Uniprot:  P56856